Recombinant Human DAXX Protein ，GST

DAXX (Death Domain-Associated Protein) is a multifunctional protein involved in diverse cellular processes, including apoptosis, transcriptional regulation, and chromatin remodeling. Research into DAXX has gained momentum due to its critical role in various human diseases, particularly cancers and neurodegenerative disorders. DAXX is known to interact with a plethora of signaling proteins, such as the tumor suppressor p53 and histone deacetylases, implicating its involvement in the modulation of gene expression and cell fate decisions. Furthermore, studies have revealed that DAXX can function both as a tumor suppressor and a potential oncogene, depending on the cellular context and mutations present. The complexity of DAXX's interactions and its dual roles have led to increased interest in understanding its structural dynamics, post-translational modifications, and the mechanisms underlying its diverse functions. Recent advancements in techniques such as X-ray crystallography and cryo-electron microscopy have paved the way for detailed analyses of DAXX's structure, providing insights into how its conformation influences its binding to various partners. As ongoing research continues to unravel the precise mechanisms by which DAXX contributes to disease pathology, it holds promise as a potential therapeutic target, making its study crucial in the pursuit of effective treatments for cancer and other associated diseases.